Hennion & Walsh Asset Management Inc. Has $695,000 Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
Hennion & Walsh Asset Management Inc. increased its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 89.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,315 shares of the company’s stock after purchasing an additional 7,235 shares during the period. […]
More Stories
Rockhopper Exploration (LON:RKH) Trading Up 13.2% – Should You Buy?
Rockhopper Exploration plc (LON:RKH – Get Free Report) shares rose 13.2% on Thursday . The stock traded as high as...
Crescent Energy (NYSE:CRGY) Sets New 52-Week High – Here’s What Happened
Crescent Energy (NYSE:CRGY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday ....
Odyssean Investment Trust (LON:OIT) Hits New 52-Week Low – Time to Sell?
Odyssean Investment Trust (LON:OIT – Get Free Report) hit a new 52-week low on Tuesday . The company traded as...
Rep. Lauren Boebert Pushes to Abolish the ATF
By Nathan Worcester Rep. Lauren Boebert (R-Colo.) has joined Rep. Eric Burlison (R-Mo.) in introducing legislation to abolish the Bureau...
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 8% – Here’s Why
Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) fell 8% on Tuesday . The stock traded as low as $18.78...
Rugby Resources (CVE:RUG) Shares Down 25% – What’s Next?
Rugby Resources Ltd. (CVE:RUG – Get Free Report)’s stock price dropped 25% on Tuesday . The stock traded as low...